CClinicalTrials.gg
Status unknownNCT02942459Updated Jul 8, 2019

Music Therapy Towards Schizophrenia, Negative Symptoms

An interventional study of Music therapy and Music Listening in Schizophrenia, sponsored by Inge Nygaard Pedersen. Status unknown at 1 site in Denmark. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2019-07-08.

Sponsored by Inge Nygaard Pedersen · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jul 2019), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Sep 2015, registered Sep 2016).
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The Aim of this National study is to examine whether music therapy can reduce negative symptoms and raise Quality of Life for patients suffering from Schizophrenia. It is an Randomized Controlled Trial (RCT), double-blinded study with two arms. 120 Participants are anticipated. The two Arms consist of 25 weekly hours of Music Therapy by educated Music Therapists and time compensated Music Listening by unknown Care Staff Members.

The Study is a close Cooperation between Aalborg University (The Music Therapy Research Clinic) and Aalborg University Hospital, Psychiatry.

Read the detailed description

Schizophrenia includes 1 % of the Population in Denmark (DK) and often ends up to be chronically. Negative Symptoms are difficult to reduce by Medication and Psychosocial Treatment Possibilities are searched for. Three Cochrane Reviews (2005, 2011, 2017) have been conducted concerning Music Therapy and Schizophrenia with Positive Results. This RCT, double-blinded Study aims at verifying, if these Results can be Recognized in the Danish Health System. It also aims at being similar to Biomedical Study Designs as much as possible to strengthen the Evidence of the Study. A Power Calculation showed, that a minimum of 44,5 Participants in each Arm should be available, but as drop out can be anticipated with this Population, 60 Participants in each Arm were recommended. The screening Procedure is Comprehensive as it aims at securing, that the negative Symptoms are part of the Illness Schizophrenia and not side Effects from Medication or simultaneous Depression (See the Inclusion- and Exclusion criteria).

The Measurement Tools are as follows:

At Baseline, after 15 Sessions and at Termination:

  • The Positive and Negative Syndrome Scale (PANSS),
  • Brief Negative Symptom Scale (BNSS),
  • Quality of Life (WHOQOL-Bref),
  • Calgary Depression Scale for Schizophrenia (CDSS),
  • Board of Clinical Examinations (Danish Questionnaire) (UKU)
  • Global Assessment of Functioning Scale (GAF) 4 Weeks after Termination Follow Up Interview. In the Arm of Music Therapy Audio Recording of Music Interventions are done in Session 1,15 and 25.
  • Helping Alliance Questionnaire, patient version, (Haq-II) This Haq-II is filled out after 5 sessions and after 15 Sessions and at Termination together with a Research Assistant in both Arms.
02

Conditions studied

  • Schizophrenia

Browse trials for

Keywords

  • music therapy
  • double-blinded
  • Randomized Controlled study (RCT)
  • Schizophrenia, negative symptoms
03

In context

Schizophrenia

3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.

This study's planned enrollment of 120 is above the median of 70 across 2,872 interventional studies indexed under Schizophrenia.

Browse Schizophrenia studies →

Lead sponsor

This is the only study on the registry with Inge Nygaard Pedersen as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18 - 65 years
  • A Diagnosis of Schizophrenia International Classification of Diseases (ICD-10 (F20))
  • The Positive and Negative Syndrome Scale (PANNS), negative subscale has to show ≥ 4 on two of the following parameters:

(N1) subdued affect, (N2) emotional withdrawal, (N3) poor contact and (N4) passive/apathetic social withdrawal.

Exclusion criteria

Exclusion Criteria:

  • Debut of schizophrenia less than 2 years ago.
  • Patients in acute worsening of schizophrenia defined as hospitalization within the last three months.
  • PANNS positive subscale (P1-P7) >28.
  • Patients who have their psychotropics changed within the last months.
  • Significant drug dependency conflicting participation in the study.
  • Presence of secondary symptoms defined as Depression - CDSS score > 7
  • Neurological side effects - UKU score > 1 in one of the following items: 2.1, 2.2, 2.3, 2.5, 2.6
  • Sedative side effects - UKU item 1.3 score > 1.
  • No individual music therapy within the last two months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Music Therapy

    25 Weekly Hours of Music Therapy adapted to the Needs of the Participants. Interventions can be Active (playing Music, singing, improvising, Song-writing) or Receptive (Listening to selected Play-lists, or to the Participants´ favored Music). A Manual is created and trained with the Music Therapists, which distinguishes between 1. Unique and Essential Principles for Music Therapy with people suffering from Schizophrenia with negative Symptoms, 2. Essential but not Unique Principles, 3. Acceptable but not necessary Principles, 4. Not acceptable and Proscribed Principles. These Principles concern Attitude and Listening Perspectives by the Music Therapist, how to conduct the Musical Interventions and Questions of Frames for the Music Therapy Work.

    Other: Music therapy

  • Active comparator
    Music Listening

    25 Weekly Hours of Being together with an unknown Care Staff Member listening to Music from selected Play-Lists. Music Therapists at the Music Therapy Research Clinic at Aalborg University Hospital, Psychiatry have developed Play-Lists in a Taxonomy from very Supportive to less Supportive Music including around 100 Hours of Music all together on the Lists. A Manual is created and trained with the Care Staff Members. Here the Activities are much more limited (only Music Listening to the Play-Lists are allowed). No Therapeutical Conversation is allowed.

    Other: Music Listening

Interventions

  • OtherMusic therapy

    25 Weekly Hours of Music Therapy by an Educated Music Therapist

  • OtherMusic Listening

    25 weekly Hours of Being Together with an unknown Care Staff Member

06

What researchers measure

Primary outcomes

  1. Changes from Baseline at 25 Sessions of Music Therapy in Negative Symptoms. Psychological Questionnaires

    The Positive and Negative Syndrome Scale (PANSS). Negative Subscale.

    Time frame: Up til 30 weeks

Secondary outcomes

  1. Change in Quality of Life from Baseline at 25 sessions. Psychological Questionnaire

    Quality of Life (WHOQOL-Bref)

    Time frame: Up till 30 weeks

  2. Functional Changes from Baseline to Termination. Psychological Questionnaire

    Global Assessment of Functioning (GAF)

    Time frame: Up to 30 weeks

  3. Changes of Anhedonic Features from Baseline at 25 Sessions of Music Therapy. Psychological Questionnaire

    Brief negative Symptom Scale (BNSS). Anhedonic Subscale.

    Time frame: Up to 30 weeks

07

Study locations

1 of 1 sites recruiting
  • Aalborg University Hospital
    Aalborg, North Jutland 9000, Denmark
    • Inge N. Pedersen, PhDAss. Prof · Contact · innp@rn.dk · +45 26229614
    • René Ernst Nielsen, PhDAss. Prof · Contact · ren@rn.dk · +45 28722962
    Recruiting
08

References and documents

Publications

  • Pedersen IN, Bonde LO, Hannibal NJ, Nielsen J, Aagaard J, Gold C, Rye Bertelsen L, Jensen SB, Nielsen RE. Music Therapy vs. Music Listening for Negative Symptoms in Schizophrenia: Randomized, Controlled, Assessor- and Patient-Blinded Trial. Front Psychiatry. 2021 Dec 21;12:738810. doi: 10.3389/fpsyt.2021.738810. eCollection 2021. PubMed 34992553 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02942459
Lead sponsor
Inge Nygaard Pedersen
Collaborators
Aalborg University
Responsible party
Inge Nygaard Pedersen (Ass. Professor. PhD, Aalborg Psychiatric Hospital) — Sponsor-investigator
First posted
Oct 24, 2016
Start date
Sep 1, 2015
Primary completion
Apr 1, 2020 (estimated)
Completion
Dec 31, 2020 (estimated)
Last update
Jul 8, 2019

Study contacts

Inge N. Pedersen, PhDAss. Prof
Contact
innp@rn.dk
+45 26229614
René Ernst Nielsen, PhDAss.Prof
Contact
ren@rn.dk
+45 28722962
Inge N. Pedersen, Ass. Prof.
principal investigator · Aalborg University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion